Hosted on MSN

AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated ...
The Boston Globe

Unleased lab space. Plunging valuations. Layoffs. In Massachusetts, the biotech slump is taking its toll.

This was supposed to be the year of biotech’s comeback. At least that was the hope of many in the sector who started 2025 pointing to scientific advances and falling interest rates. Some foresaw a ...
The Business Journals

Biogen lays out three FDA decisions that could ramp up Alzheimer's drug launch

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Since its approval in 2023, the ...
The Business Journals

From Medford to Harvard: How a summer program shaped Eleanor Nkera's scientific journey

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Cambridge-based company's ...
STAT

We’re reading about an FDA quality lab lease, Marty Makary’s confirmation hearing, and more

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...